医薬品開発製造受託機関（CMO）の世界市場レポート 2025年

医薬品開発製造受託機関（CMO）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で2,608億3,000万米ドルに成長します。予測期間の成長は、政府支援の増加、ヘルスケアへのアクセスの増加、投資の増加、バイオ医薬品開発の増加が市場を牽引するためと考えられます。予測期間における主な動向としては、持続可能性への注目の高まり、人工知能とデジタル化の統合への注目、回復力に焦点を当てた革新的な製品、投資の増加、市場プレイヤー間の戦略的パートナーシップやコラボレーションなどが挙げられます。

医薬品開発・製造受託市場の拡大には、世界の医薬品需要の増加が寄与しています。疾病の蔓延の高まりと寿命延長への願望が相まって、医薬品需要が急増しています。このため、製薬会社は既存の医薬品の生産を強化し、新薬の創出を促進するために研究開発（R&D）投資を拡大しています。こうした需要に対応するため、製薬会社は業務コスト削減の戦略的アプローチとして製造受託機関（CMO）との提携を進めており、医薬品開発・製造受託市場の需要拡大を促進しています。バイオ医薬品企業のアルカーメスPLCによると、医薬品受託製造は、コスト削減の必要性から、大企業から小規模の特殊製薬企業まで、さまざまな規模の企業にとって戦略的な選択肢となりつつあります。

医薬品開発・製造受託市場の成長が期待される背景には、特許切れの深刻化があります。特許の失効は、発明者または特許権者に与えられた法的に保護された独占的権利が特定の期間終了し、発明の製造、販売、使用が可能になることを意味します。医薬品の受託開発・製造は、ジェネリック医薬品の迅速な開発・製造を促進し、特許満了後の市場開拓を可能にするという重要な役割を担っています。例えば、米国のウェブサービス・プラットフォームであるドラッグ・パテント・ウォッチ（DrugPatentWatch）によると、2023年には合計37品目の医薬品が特許切れを迎え、ジェネリック医薬品市場参入への道が開かれます。その結果、特許切れの増加は医薬品開発・製造受託市場の重要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医薬品開発製造受託機関（CMO） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医薬品開発製造受託機関（CMO）市場：成長率分析
• 世界の医薬品開発製造受託機関（CMO）市場の実績：規模と成長, 2019-2024
• 世界の医薬品開発製造受託機関（CMO）市場の予測：規模と成長, 2024-2029, 2034F
• 世界医薬品開発製造受託機関（CMO）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品開発製造受託機関（CMO）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 契約製造サービス
• 契約調査サービス
• 世界の医薬品開発製造受託機関（CMO）市場調査段階別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前臨床
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV
• 世界の医薬品開発製造受託機関（CMO）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大手製薬会社
• ジェネリック医薬品会社
• 中小製薬企業
• 世界の医薬品開発製造受託機関（CMO）市場、契約製造サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品有効成分（API）製造
• 処方開発
• 完成剤形の製造
• 梱包サービス
• サプライチェーンマネジメント
• 世界の医薬品開発製造受託機関（CMO）市場、契約調査サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前調査サービス
• 臨床試験管理
• 規制関連コンサルティング
• 生物統計学とデータ管理
• 分析および試験サービス

第7章 地域別・国別分析

• 世界の医薬品開発製造受託機関（CMO）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品開発製造受託機関（CMO）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品開発製造受託機関（CMO）市場：競合情勢
• 医薬品開発製造受託機関（CMO）市場：企業プロファイル
  • Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • WuXi AppTec Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Almac Group
• Aenova Group
• Baxter International Inc
• SGS Life Science Services SA
• Jubilant Pharmova Ltd
• Dishman Pharmaceuticals
• Kemwell Pvt. Ltd.
• Nipro Corp.
• CMIC Group
• Sawai Pharmaceutical Co., Ltd
• IDT Australia Limited
• Aurigene Pharmaceutical Services Limited
• Vetter Pharma International GMBH
• Consort Medical PLC
• Siegfried Holding AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品開発製造受託機関（CMO）市場2029：新たな機会を提供する国
• 医薬品開発製造受託機関（CMO）市場2029：新たな機会を提供するセグメント
• 医薬品開発製造受託機関（CMO）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical Contract Development and Manufacturing (CDMO) involves businesses that provide services for drug research and manufacturing in the pharmaceutical sector. Pharmaceutical companies can choose to outsource drug development and production by partnering with CDMOs. Full-service CDMOs are capable of managing every stage of the process, accommodating clients who wish to outsource specific steps in their workflow. The services provided are tailored to the specific requirements of each client.

Pharmaceutical Contract Development and Manufacturing Organizations (CMO) primarily offer contract manufacturing services and contract research services. Contract manufacturing services involve outsourcing manufacturing processes or goods production to a third-party company, commonly known as a contract manufacturer. The research phases encompass preclinical, phase I, phase II, phase III, and phase IV. End-use sectors for CDMOs include large pharmaceutical companies, generic pharmaceutical companies, and small to medium-sized pharmaceutical companies.

The pharmaceutical contract development and manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing market statistics, including pharmaceutical contract development and manufacturing industry global market size, regional shares, competitors' pharmaceutical contract development and manufacturing market share, detailed pharmaceutical contract development and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing industry. This pharmaceutical contract development and manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical contract development and manufacturing organization (CMO) market size has grown strongly in recent years. It will grow from $174.33 billion in 2024 to $186.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, rising healthcare expenditure, increase in pharmaceutical research and development (R&D) expenditure and increasing preference for outsourcing.

The pharmaceutical contract development and manufacturing organization (CMO) market size is expected to see strong growth in the next few years. It will grow to $260.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing government support, increase in healthcare access, increase in investments and increase in biopharmaceutical development will drive the market. Major trends in the forecast period include increased focus on sustainability, focus on integration of artificial intelligence and digitalization, innovative products with focus on resilience, increasing investments and strategic partnerships and collaborations among market players.

The expansion of the pharmaceutical contract development and manufacturing market is fueled by the global increase in demand for medicines. The heightened prevalence of diseases, coupled with the desire for longer lifespans, has led to a surge in the demand for medications. This, in turn, has prompted pharmaceutical companies to intensify the production of existing drugs and augment their research and development (R&D) investments to facilitate the creation of new drugs. In response to these demands, pharmaceutical companies are engaging in collaborations with contract manufacturing organizations (CMOs) as a strategic approach to reducing operational costs, thereby fostering an elevated demand for the pharmaceutical contract development and manufacturing market. According to Alkermes PLC, a biopharmaceutical company, pharmaceutical contract manufacturing is becoming a strategic choice for companies of varying sizes, from large enterprises to smaller specialty pharma entities, driven by the imperative to cut costs.

The anticipated growth in the pharmaceutical contract development and manufacturing market is further propelled by the escalating phenomenon of patent expiration. Patent expiration signifies the conclusion of the legally protected exclusive rights granted to an inventor or patent holder for a specified duration, allowing them to make, sell, or use the invention. Pharmaceutical contract development and manufacturing play a crucial role in facilitating the rapid development and production of generic drugs, enabling their entry into the market upon the expiration of patents. For example, in 2023, DrugPatentWatch, a US-based web service platform, reports that a total of 37 drugs are set to face patent expirations, paving the way for generic market entry. Consequently, the increasing patent expiration is a significant driver for the pharmaceutical contract development and manufacturing market.

Pharmaceutical contract development and manufacturing companies are actively engaging in acquisitions and forming strategic alliances to strengthen their market presence. This trend reflects a strategic focus on expanding global market reach, meeting client requirements, enhancing production capabilities, and gaining access to cutting-edge technology and new services. The heightened frequency of merger and acquisition activities has led to the consolidation of contract service providers within the industry. For example, in July 2022, Pharma Nobis, a US-based provider of contract manufacturing and private label services, acquired Fagron's U.S. contract manufacturing business. This strategic move allows Pharma Nobis to extend contract manufacturing and private label services to American retailers and consumer healthcare corporations, with Fagron retaining a 20% ownership stake in the company.

Leading companies in the pharmaceutical contract development and manufacturing market are innovating their service portfolios to cater to evolving industry needs. One such offering is the DevPack, a service designed to optimize processes across multiple partners and create a standardized dataset for development process steps. ASM Research Chemicals, a Germany-based company providing contract research and manufacturing services, launched the DevPack service in May 2023. Tailored for active pharmaceutical ingredients (APIs) manufacturing, DevPack streamlines API research, development, and scale-up. It is particularly beneficial for Contract Manufacturing Organizations (CMOs) and pharmaceutical firms aiming for rapid early-stage manufacturing route development, along with supporting analytical development and regulatory submissions.

In August 2022, Catalent, Inc., a US-based provider of delivery technologies, development, and drug manufacturing, completed the acquisition of Metrics Contract Services for $475 million. This strategic move enhances Catalent's capabilities in working with highly potent chemicals and strengthens its expertise in integrated oral solid formulation research, production, and packaging. The acquisition is aimed at assisting clients in streamlining and expediting their processes. Metrics Contract Services is a US-based pharmaceutical contract development and manufacturing organization.

Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratorios S.A., Ache Laboratorios Farmaceuticos S.A., Blanver Farmoquimica e Farmaceutica S.A., Prati-Donaduzzi, Uniao Quimica Farmaceutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals

North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical contract development and manufacturing organization (CMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical contract development and manufacturing organization (cmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (cmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical contract development and manufacturing organization (cmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Contract Manufacturing Services, Contract Research Services
• 2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
• 2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
• Subsegments:
• 1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing; Formulation Development; Finished Dosage Form Manufacturing; Packaging Services; Supply Chain Management
• 2) By Contract Research Services: Preclinical Research Services; Clinical Trial Management; Regulatory Affairs Consulting; Biostatistics And Data Management; Analytical And Testing Services
• Companies Mentioned: Lonza Group; Catalent Inc; WuXi AppTec Inc.; Pfizer Inc; Recipharm AB
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

4. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Total Addressable Market (TAM)

6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

• 6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Manufacturing Services
• Contract Research Services
• 6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Big Pharmaceutical Companies
• Generic Pharmaceutical Companies
• Small And Medium-Sized Pharmaceutical Companies
• 6.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Manufacturing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Pharmaceutical Ingredient (API) Manufacturing
• Formulation Development
• Finished Dosage Form Manufacturing
• Packaging Services
• Supply Chain Management
• 6.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Research Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Research Services
• Clinical Trial Management
• Regulatory Affairs Consulting
• Biostatistics And Data Management
• Analytical And Testing Services

7. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 11.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 14.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 18.1. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 19.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 20.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 21.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 21.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 22.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 23.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 23.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 24.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 24.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 25.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 25.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 26.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 26.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 27.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 28.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 28.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 29.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• 29.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape
• 30.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles
  • 30.2.1. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. WuXi AppTec Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Other Major And Innovative Companies

• 31.1. Almac Group
• 31.2. Aenova Group
• 31.3. Baxter International Inc
• 31.4. SGS Life Science Services SA
• 31.5. Jubilant Pharmova Ltd
• 31.6. Dishman Pharmaceuticals
• 31.7. Kemwell Pvt. Ltd.
• 31.8. Nipro Corp.
• 31.9. CMIC Group
• 31.10. Sawai Pharmaceutical Co., Ltd
• 31.11. IDT Australia Limited
• 31.12. Aurigene Pharmaceutical Services Limited
• 31.13. Vetter Pharma International GMBH
• 31.14. Consort Medical PLC
• 31.15. Siegfried Holding AG

32. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

34. Recent Developments In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

35. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer